QualityStocksNewsBreaks – TFF Pharmaceuticals Inc. (NASDAQ: TFFP) Closes $40M Follow-On Offering
TFF Pharmaceuticals (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (“TFF”) technology platform, announced that it has closed on its recent underwritten offering. The offering comprised 2,855,000 shares of TFFP common stock sold at the offering price of $14 per share. The announcement noted that 2,140,000 shares were sold by TFF Pharmaceuticals and 715,000 shares were sold by Lung Therapeutics Inc., a privately held company. The public offering resulted in approximately $40 million gross proceeds for TFF Pharmaceuticals. The company noted that it anticipated using its portion…
